Oragenics, Inc. Prices Public Offering Of Common Stock

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE MKT: OGEN) (the “Company”) announced today that it has priced an underwritten public offering of 4,400,000 shares of its common stock at a public offering price of $2.50 per share for aggregate gross proceeds of $11.0 million, prior to underwriting discounts and offering expenses. The offering is expected to close on or about November 20 2013, subject to satisfaction of customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.